Menopausal transition: A possible risk factor for brain pathologic events

Neurobiology of Aging

Volumn 30, Issue 1, 2009, Pages 71-80

  Bonomo, S M ^a   Rigamonti, A E ^a   Giunta, M ^a   Galimberti, D ^a   Guaita, A ^b   Gagliano, M G ^c   Muller E E ^a   Cella, S G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Geriatric Institute Camillo Golgi   (Italy)

^c SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Alzheimers disease; CD36; Estrogen receptors; Glucocorticoid receptors; Hormone receptors; IL 6; Leukocytes; Menopausal transition

Indexed keywords

CD36 ANTIGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; HYDROCORTISONE; INTERLEUKIN 6; PRASTERONE; PRASTERONE SULFATE;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CLIMACTERIUM; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; LEUKOCYTE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM; RISK FACTOR; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CYTOKINES; FEMALE; HORMONES; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 56249092100     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.05.017     Document Type: Article

References (60)

1. Bachman D.L., Wolf P.A., Linn R., Knoefel J.E., Cobb J., Belanger A., D'Agostino R.B., and White L.R. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 42 1 (1992) 115-119
2. Bachman D.L., Wolf P.A., Linn R.T., Knoefel J.E., Cobb J.L., Belanger A.J., White L.R., and D'Agostino R.B. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 43 3 Pt 1 (1993) 515-519
3. Bamberger C.M., Bamberger A.M., de Castro M., and Chrousos G.P. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95 (1995) 2435-2441
4. Baulieu E.E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52 (1997) 1-32
5. Ben-Hur H., Mor G., Insler V., Blickstein I., Amir-Zaltsman Y., Sharp A., Globerson A., and Kohen F. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. Am. J. Reprod. Immunol. 34 6 (1995) 363-369
6. Brayne C., Gill C., Huppert F.A., Barkley C., Gehlhaar E., Girling D.M., O'Connor D.W., and Paykel E.S. Incidence of clinically diagnosed subtypes of dementia in an elderly population: Cambridge Project for Later Life. Br. J. Psychiatry 167 (1995) 255-262
7. Brinton R.D., Chen S., Montoya M., Hsieh D., and Minaya J. The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease. Maturitas 34 Suppl. 2 (2000) S35-S52
8. Chakraborty T.R., Rajendren G., and Gore A.C. Expression of estrogen receptor {alpha} in the anteroventral periventricular nucleus of hypogonadal mice. Exp. Biol. Med. (Maywood) 230 1 (2005) 49-56
9. Chiueh C., Lee S., Andoh T., and Murphy D. Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen. Endocrine 21 1 (2003) 27-31
10. Christie R.H., Freeman M., and Hyman B.T. Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am. J. Pathol. 148 2 (1996) 399-403
11. Coraci I.S., Husemann J., Berman J.W., Hulette C., Dufour J.H., Campanella G.K., Luster A.D., Silverstein S.C., and El-Khoury J.B. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol. 160 1 (2002) 101-112
12. den Heijer T., Geerlings M.I., Hofman A., de Jong F.H., Launer L.J., Pols H.A., and Breteler M.M. Higher estrogen levels are not associated with larger hippocampi and better memory performance. Arch. Neurol. 60 2 (2003) 213-220
13. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., and Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382 6593 (1996) 716-719
14. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., Hsia J., Margolis K.L., Hogan P.E., Wallace R., Dailey M., Freeman R., Hays J., and Women's Health Initiative Memory Study. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 24 (2004) 2959-2968
15. Gao S., Hendrie H.C., Hall K.S., and Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 55 9 (1998) 809-815
16. Gibbs R.B., and Aggarwal P. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Horm. Behav. 34 2 (1998) 98-111
17. Giunta, M., Rigamonti, A.E., Scarpini, E., Galimberti, D., Bonomo, S.M., Venturelli, E., Müller, E.E., Cella, S.G., 2006. The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging.
18. Granholm A.C., Ford K.A., Hyde L.A., Bimonte H.A., Hunter C.L., Nelson M., Albeck D., Sanders L.A., Mufson E.J., and Crnic L.S. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome. Physiol. Behav. 77 2-3 (2002) 371-385
19. Granholm A.C., Sanders L., Seo H., Lin L., Ford K., and Isacson O. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome. Hippocampus 13 8 (2003) 905-914
20. Herbert J. Neurosteroids, brain damage, and mental illness. Exp. Gerontol. 33 7-8 (1998) 713-727
21. Hori T., Nakashima T., Take S., Kaizuka Y., Mori T., and Katafuchi T. Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res. Bull. 27 3-4 (1991) 309-313
22. Husemann J., Loike J.D., Kodama T., and Silverstein S.C. Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar beta-amyloid. J. Neuroimmunol. 114 1-2 (2001) 142-150
23. Jacobs D.M., Tang M.X., Stern Y., Sano M., Marder K., Bell K.L., Schofield P., Dooneief G., Gurland B., and Mayeux R. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 50 2 (1998) 368-373
24. Kesslak J.P. Can estrogen play a significant role in the prevention of Alzheimer's disease?. J. Neural Transm. Suppl. 62 (2002) 227-239
25. Kim S.U., and de Vellis J. Microglia in health and disease. J. Neurosci. Res. 81 (2005) 302-313
26. Lambert J.C., Coyle N., and Lendon C. The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease. J. Med. Genet. 41 2 (2004) 104-112
27. Leranth C., Roth R.H., Elsworth J.D., Naftolin F., Horvath T.L., and Redmond Jr. D.E. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J. Neurosci. 20 23 (2000) 8604-8609
28. Maki P.M., and Resnick S.M. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage 14 4 (2001) 789-801
29. Maki P.M., and Resnick S.M. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol. Aging 21 2 (2000) 373-383
30. 2. J. Exp. Med. 188 12 (1998) 2257-2265
31. McEwen B. Estrogen actions throughout the brain. Recent Prog. Horm. Res. 57 (2002) 357-384
32. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
33. Metha R.R., Valcourt L., Graves J., Green R., and Das Gupta T.K. Subcellular concentrations of estrone, estradiol, androstenedione and 17 beta-hydroxysteroid dehydrogenase (17-beta-OH-SDH) activity in malignant and non-malignant human breast tissues. Int. J. Cancer 40 3 (1987) 305-308
34. Meza-Munoz D.E., Fajardo M.E., Perez-Luque E.L., and Malacara J.M. Factors associated with estrogen receptors-alpha (ER-alpha) and -beta (ER-beta) and progesterone receptor abundance in obese and non-obese pre- and post-menopausal women. Steroids 71 6 (2006) 498-503
35. Miller D.B., and O'Callaghan J.P. Aging, stress and the hippocampus. Ageing Res. Rev. 4 2 (2005) 123-140
36. Mor G., Nilsen J., Horvath T., Bechmann I., Brown S., Garcia-Segura L.M., and Naftolin F. Estrogen and microglia: a regulatory system that affects the brain. J. Neurobiol. 40 4 (1999) 484-496
37. Müller E.E. Steroids, cognitive processes and aging. Recent Prog. Med. 92 5 (2001) 362-372
38. Murialdo G., Barreca A., Nobili F., Rollero A., Timossi G., Gianelli M.V., Copello F., Rodriguez G., and Polleri A. Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia. J. Endocrinol. Invest 24 3 (2001) 139-146
39. Nelson L.R., and Bulun S.E. Estrogen production and action. J. Am. Acad. Dermatol. 45 3 Suppl. (2001) S116-S124
40. Nilsson L.V. Incidence of severe dementia in an urban sample followed from 70 to 79 years of age. Acta Psychiat. Scand. 70 (1984) 478-486
41. Packan D.R., and Sapolsky R.M. Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity. Neuroendocrinology 51 6 (1990) 613-618
42. Papassotiropoulos A., Hock C., and Nitsch R.M. Genetics of interleukin 6: implications for Alzheimer's disease. Neurobiol. Aging 22 6 (2001) 863-871
43. Pfeilschifter J., Koditz R., Pfohl M., and Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 23 1 (2002) 90-119
44. Phillips S.M., and Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17 5 (1992) 485-495
45. Ritchie K., and Kildea D. Is senile dementia "age-related" or "ageing-related"?-evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 346 8980 (1995) 931-934
46. Salem M.L. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr. Drug Targets Inflamm. Allergy 3 1 (2004) 97-104
47. Santner S.J., Ohlsson-Wilhelm B., and Santen R.J. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures. Int. J. Cancer 54 1 (1993) 119-124
48. Sapolsky R.M., Stein-Behrens B.A., and Armanini M.P. Long-term adrenalectomy causes loss of dentate gyrus and pyramidal neurons in the adult hippocampus. Exp. Neurol. 114 2 (1991) 246-249
49. Schreihofer D.A., Stoler M.H., and Shupnik M.A. Differential expression and regulation of estrogen receptors (ERs) in rat pituitary and cell lines: estrogen decreases ERalpha protein and estrogen responsiveness. Endocrinology 141 6 (2000) 2174-2184
50. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., Fillit H., Stefanick M.L., Hendrix S.L., Lewis C.E., Masaki K., Coker L.H., and Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 24 (2004) 2947-2958
51. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones III B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., Wactawski-Wende J., and WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 20 (2003) 2651-2662
52. Simpson E.R. Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol. 86 3-5 (2003) 225-230
53. Smith J.D., and Levin-Allerhand J.A. Potential use of estrogen-like drugs for the prevention of Alzheimer's disease. J. Mol. Neurosci. 20 3 (2003) 277-281
54. Thomas T., and Rhodin J. Vascular actions of estrogen and Alzheimer's disease. Ann. NY Acad. Sci. 903 (2000) 501-509
55. Turgeon J.L., Carr M.C., Maki P.M., Mendelsohn M.E., and Wise P.M. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocr. Rev. 27 6 (2006) 575-605
56. Vallee M., Mayo W., and Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res. Rev. 37 1-3 (2001) 301-312
57. Vermeulen A., Kaufman J.M., Goemaere S., and van Pottelberg I. Estradiol in elderly men. Aging Male 5 2 (2002) 98-102
58. Yen S.S., Morales A.J., and Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann. NY Acad. Sci. 774 (1995) 128-142
59. Yudt M.R., and Cidlowski J.A. The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. Mol. Endocrinol. 16 8 (2002) 1719-1726
60. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., Breitner J.C., and Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288 17 (2002) 2123-2129